Research
Cellular
Sarcopenic diabetes is recognized as a distinct clinical condition that requires more awareness and research.
There is a need for increased focus on sarcopenic diabetes in clinical practice and research.
StrongSupportsmedium confidence
The European Society for Clinical Nutrition and Metabolism (ESPEN) and the Diabetes Nutrition Study Group (DNSG) recognize sarcopenic diabetes as a distinct clinical condition and priority for research and education.
Why this rating
The claim is supported by authoritative organizations in the field.
Source
Sarcopenic diabetes is an under-recognized and unmet clinical priority. A call for action from the European Society for Clinical Nutrition and Metabolism and the Diabetes Nutrition Study Group
Rocco Barazzoni et al. · Clinical Nutrition · 2025
DOI 10.1016/j.clnu.2025.10.007
otherCited 6×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Cellular
- Athletes aiming to reduce fat mass and preserve FFM should consume protein intakes in the range of ∼1.8-2.7 g kg(-1) d(-1).Strong
- A minimum daily protein intake of ≥1.6 g/kg is necessary to observe significant improvements in muscle mass from whey protein supplementation.Strong
- Most athletes ideally need 1.2 to 2.0 grams/kg of body weight/day of protein, preferably split across 3-4 meals.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →